BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7856633)

  • 1. Unit dose dispensing of chromic phosphate P 32 suspension.
    Hung JC
    Am J Hosp Pharm; 1994 Dec; 51(24):3081. PubMed ID: 7856633
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioactive chromic phosphate suspension: studies on distribution, dose absorption, and effective therapeutic radiation in phantoms, dogs, and patients.
    Currie JL; Bagne F; Harris C; Sullivan DL; Surwit EA; Wilkinson RH; Creasman WT
    Gynecol Oncol; 1981 Oct; 12(2 Pt 1):193-218. PubMed ID: 7297930
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose estimation to the infant from breast milk following intraperitoneal administration of chromic phosphate 32P for the treatment of early ovarian cancer.
    Sharma SC; Osborne RP; Jose B; Carlson JA
    Health Phys; 1984 Sep; 47(3):452-4. PubMed ID: 6500947
    [No Abstract]   [Full Text] [Related]  

  • 4. Phosphorus-32-colloidal chromic phosphate: treatment of choice for malignant pericardial effusion.
    Sprengelmeyer JT; McDermott RL
    J Nucl Med; 1990 Dec; 31(12):2034-6. PubMed ID: 2266403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant internal hepatic radiotherapy using colloidal 32P chromic phosphate in colorectal cancer.
    Kim JY; Bom HS; Kim YJ; Choi W
    Radiat Med; 1990; 8(6):246-9. PubMed ID: 2093946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal radioactive chromic phosphate (P32) in the treatment of ovarian cancer.
    Powell JL; Kirchner AB
    J Med Assoc Ga; 1984 Jan; 73(1):21-5. PubMed ID: 6707541
    [No Abstract]   [Full Text] [Related]  

  • 7. Pleuroperitoneal migration of intraperitoneal phosphorus-32-chromic phosphate therapy for stage I ovarian carcinoma.
    Wilkinson RH
    J Nucl Med; 1996 Apr; 37(4):636-9. PubMed ID: 8691256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal chromic phosphate in ovarian cancer: risks and benefits.
    Potter ME; Partridge EE; Shingleton HM; Soong SJ; Kim RY; Hatch KD; Austin JM
    Gynecol Oncol; 1989 Mar; 32(3):314-8. PubMed ID: 2920951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemarthrosis and synovitis associated with hemophilia: clinical use of P-32 chromic phosphate synoviorthesis for treatment.
    Siegel HJ; Luck JV; Siegel ME; Quines C; Anderson E
    Radiology; 1994 Jan; 190(1):257-61. PubMed ID: 8259416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioactivity in breast milk after intraperitoneal chromic phosphate for the treatment of early ovarian cancer.
    Carlson JA; Jose B; Sharma SC; Osborne RP
    Am J Obstet Gynecol; 1983 Dec; 147(7):840-1. PubMed ID: 6650612
    [No Abstract]   [Full Text] [Related]  

  • 11. An early phase II study of intratumoral P-32 chromic phosphate injection therapy for patients with refractory solid tumors and solitary metastases.
    Firusian N; Dempke W
    Cancer; 1999 Feb; 85(4):980-7. PubMed ID: 10091778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral injection of 32P-chromic phosphate in the treatment of implanted pancreatic carcinoma.
    Gao W; Liu L; Liu ZY; Wang Y; Jiang B; Liu XN
    Cancer Biother Radiopharm; 2010 Apr; 25(2):215-24. PubMed ID: 20423235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the role of radiotherapy in ovarian cancer.
    Lanciano R; Reddy S; Corn B; Randall M
    Semin Oncol; 1998 Jun; 25(3):361-71. PubMed ID: 9633849
    [No Abstract]   [Full Text] [Related]  

  • 14. Design and bioevaluation of a 32P-patch for brachytherapy of skin diseases.
    Salgueiro MJ; DurĂ¡n H; Palmieri M; Pirchio R; Nicolini J; Ughetti R; Papparella ML; Casale G; Zubillaga M
    Appl Radiat Isot; 2008 Mar; 66(3):303-9. PubMed ID: 17954028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radio-active colloidal chromic phosphate in the treatment of carcinoma of the urinary bladder.
    CANOY NR
    J Philipp Med Assoc; 1957 Jun; 33(6):481-6. PubMed ID: 13449721
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of malignant tumors of the bladder with radiophosphorus-labeled colloidal chromic phosphate].
    CHEVALLIER A; BURG C; BLUM E
    Sem Hop; 1955 Apr; 31(23):1318-20. PubMed ID: 14385856
    [No Abstract]   [Full Text] [Related]  

  • 17. Colloidalradioisotope therapy in leukemia with special reference to chromic phosphate P-32.
    HILL JM; SPEER RJ; MARSHALL GJ; LAJOUS JR
    Sang; 1955; 26(2):195-212. PubMed ID: 14396236
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intraperitoneal irradiation in limited epithelial neoplasms of the ovary. Review of the literature].
    Wolff JP; Burini GA
    Minerva Ginecol; 1985; 37(7-8):407-13. PubMed ID: 3906441
    [No Abstract]   [Full Text] [Related]  

  • 19. Intraperitoneal radioactive phosphate in early ovarian carcinoma: an analysis of complications.
    Walton LA; Yadusky A; Rubinstein L
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):939-44. PubMed ID: 2022522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the effect of a colloidal radioactive chromic phosphate (Cr32PO4) in clincal and experimental malignant effusions.
    VAN DEN BRENK HA; CLARKE KH; HOLMAN WP; WINKLER C
    Br J Cancer; 1959 Jun; 13(2):181-94. PubMed ID: 13841011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.